V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190010459 | 190003117 | 1.83 | 82 | Palliative (P) | 2017-01-01 | 2017-01-02 | OST Euramos 1 Closed Trial - AP | 02 | N | OST AP | 101317669 |
| 190010460 | 190003118 | 1.43 | 24.2 | Palliative (P) | 2018-10-23 | 2018-10-24 | OCTREOTIDE | 02 | N | GC INT GUIDE EXCRANIAL GERMCELL JEB | 101068561 |
| 190010465 | 190003120 | 1.51 | 62.8 | Palliative (P) | 2018-11-18 | 2018-12-04 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | CARBOPLATIN + ETOPOSIDE | 100989131 |
| 190010472 | 190003122 | 1.84 | 50.8 | Palliative (P) | 2018-07-17 | 2018-07-25 | OST Euramos 1 Closed Trial - AP | 02 | N | OST AP | 101104561 |
| 190010473 | 190003123 | 1.72 | 65.4 | Curative (C) | 2019-03-11 | 2019-03-21 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 100010762 |
| 190010478 | 190003124 | null | null | null | null | 2019-12-29 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100185268 |
| 190010480 | 190003125 | null | null | null | null | 2017-07-10 | Trial Unspecified | null | null | NB HRNBL-1 COJEC IND COURSE A | 101828403 |
| 190010487 | 190003127 | null | null | null | null | 2016-11-01 | EW EuroEwing 2012 Arm A VIDE | null | null | MAP | 100607442 |
| 190010488 | 190003128 | null | null | null | null | 2018-04-24 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100741561 |
| 190010489 | 190003129 | null | null | null | null | 2019-11-25 | Oxaliplatin + Modified de Gramont | null | null | STS NON-RHABDO EPSSG 2005 IE | 101355114 |
| 190010492 | 190003130 | 1.76 | 57 | Adjuvant (A) | 2013-06-07 | 2013-06-25 | Oxaliplatin + Modified de Gramont | 02 | Y | MAP | 100561917 |
| 190010494 | 190003131 | null | null | null | null | 2020-01-24 | VIDE | null | null | DHAP | 100165736 |
| 190010500 | 190003132 | null | null | null | null | 2018-08-24 | Cisplatin + Fluorouracil + RT 5day | null | null | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 101662835 |
| 190010501 | 190003133 | 1.69 | 90 | Curative (C) | 2019-11-21 | 2019-11-30 | Doxorubicin + Ifosfamide | 02 | N | CISPLATIN | 101770256 |
| 190010503 | 190003135 | null | null | null | null | 2017-07-15 | DOXORUBICIN | null | null | TRIAL | 100345006 |
| 190010506 | 190003136 | 1.49 | 81.7 | Curative (C) | 2019-04-14 | 2019-04-18 | Dox + HD Mtx (post PAM) | N | Y | EURO-EWING | 101489551 |
| 190010509 | 190003137 | null | null | null | null | 2017-06-07 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 100277654 |
| 190010510 | 190003138 | null | null | null | null | 2017-10-10 | Cisplatin + Etoposide po&iv 3 day | null | null | DOXORUBICIN + METHOTREXATE | 101045967 |
| 190010513 | 190003139 | null | null | null | null | 2018-09-10 | FCarboSt | null | null | TRIAL | 100959584 |
| 190010514 | 190003140 | null | null | null | null | 2016-08-24 | CETUXIMAB + RT | null | null | TRIAL | 101751812 |
| 190010515 | 190003141 | null | null | null | null | 2017-09-07 | Bortezomib + CYCLOPHOSPHAMIDE + Dexamethasone | null | null | EURAMOS TRIAL | 101590048 |
| 190010519 | 190003142 | 1.68 | 77.1 | Palliative (P) | 2017-08-18 | 2017-08-29 | Carboplatin + Vinorelbine Oral | 02 | Y | EURAMOS TRIAL | 101510696 |
| 190010520 | 190003143 | null | null | null | null | 2019-05-17 | Carboplatin AUC 2 - 5 | null | null | CARBOPLATIN + ETOPOSIDE | 101789681 |
| 190010523 | 190003144 | 1.58 | 68.9 | Curative (C) | 2016-07-24 | 2016-08-08 | Dox + HD Mtx (post PAM) | 2 | Y | TRIAL | 100632183 |
| 190010527 | 190003145 | 1.58 | 70.2 | Palliative (P) | 2018-09-24 | 2018-10-07 | Cisplatin + Pemetrexed | 02 | N | TRIAL UNSPECIFIED | 100768930 |
| 190010529 | 190003146 | null | null | null | null | 2017-05-20 | Doxorubicin + Ifosfamide | null | null | DOXORUBICIN + HD MTX | 100610449 |
| 190010531 | 190003148 | 1.67 | 83.6 | Neo-adjuvant (N) | 2017-12-15 | 2017-12-23 | VDC | N | N | EURO-EWING | 101243341 |
| 190010535 | 190003150 | 1.7 | 80 | Adjuvant (A) | 2017-11-12 | 2017-11-26 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 101646211 |
| 190010537 | 190003151 | null | null | null | null | 2017-11-06 | Capecitabine + Oxaliplatin 21day | null | null | MAP | 101289076 |
| 190010539 | 190003152 | 1.66 | 71.2 | null | 2016-03-15 | 2016-03-22 | EOX | 02 | null | CYCLOPHOSPHAMIDE | 101446744 |
| 190010540 | 190003153 | null | null | null | null | 2018-12-06 | CAPECITABINE + OXALIPLATIN | null | null | EW EUROEWING 2012 ARM A VIDE | 101310410 |
| 190010544 | 190003154 | 1.77 | 135 | Curative (C) | 2019-08-11 | 2019-09-04 | GC Int Guide Excranial GermCell JEB | 02 | Y | DOXORUBICIN | 100047691 |
| 190010550 | 190003157 | null | null | null | null | 2018-09-21 | Pazopanib | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101131771 |
| 190010551 | 190003158 | null | null | null | null | 2017-04-21 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 101698758 |
| 190010553 | 190003160 | null | null | null | null | 2017-06-15 | EOX | null | null | CARBOPLATIN + ETOPOSIDE | 100608035 |
| 190010554 | 190003161 | null | null | null | null | 2018-04-23 | CISPLATIN + ETOPOSIDE | null | null | TRIAL | 101448429 |
| 190010555 | 190003162 | null | 49.7 | Palliative (P) | 2019-05-28 | 2019-06-07 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 100798334 |
| 190010563 | 190003163 | null | null | null | null | 2018-05-13 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN | 101796420 |
| 190010565 | 190003164 | 1.62 | 28 | Curative (C) | 2020-06-07 | 2020-06-22 | ECX | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100118594 |
| 190010566 | 190003165 | null | null | null | null | 2019-07-27 | CARBOPLATIN | null | null | TRIAL | 101178459 |
| 190010570 | 190003166 | 1.1 | 78 | Curative (C) | 2016-03-02 | 2016-03-20 | Cisplatin + Doxorubicin | 01 | null | CISPLATIN + DOXORUBICIN | 101641547 |
| 190010572 | 190003168 | null | null | null | null | 2016-12-16 | Gemcitabine 1000mg/m2 D1 8 15 | null | null | DOXORUBICIN + HD MTX | 101726828 |
| 190010577 | 190003169 | 0 | 64 | Curative (C) | 2019-09-15 | 2019-09-16 | OST Euramos 1 Closed Trial - AP | N | N | OST AP | 100426967 |
| 190010592 | 190003174 | null | null | null | 2021-06-21 | 2021-07-06 | Carboplatin AUC 2 - 5 | 02 | null | CHOP R | 100205649 |
| 190010593 | 190003175 | 1.79 | 68.7 | Palliative (P) | 2019-03-19 | 2019-03-19 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 101788187 |
| 190010596 | 190003176 | 1.66 | 49.6 | Curative (C) | 2018-03-23 | 2018-03-23 | Doxorubicin + Ifosfamide | 02 | N | EW EUROEWING 2012 ARM A VIDE | 100167309 |
| 190010597 | 190003177 | 1.63 | 56 | Neo-adjuvant (N) | 2017-12-15 | 2017-12-15 | Cisplatin + Doxorubicin | 01 | N | CISPLATIN + DOXORUBICIN | 100364039 |
| 190010598 | 190003178 | 1.68 | 82.6 | Curative (C) | 2017-12-16 | 2017-12-22 | ECX | 02 | N | TRABECTEDIN | 101068976 |
| 190010604 | 190003179 | 1.7 | 86.8 | Neo-adjuvant (N) | 2017-07-11 | 2017-07-12 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 101695167 |
| 190010605 | 190003180 | null | null | null | null | 2019-09-26 | Cisplatin + Etoposide (3 day) | null | null | MAP | 101120683 |